Matrix metalloproteinase-2 activation modulates glioma cell migration.

Stable transfection of U251.3 glioma cells with cDNA encoding MT-MMP-1 resulted in increased cell surface expression of MT-MMP-1 and TIMP-2, constitutive activation of MMP-2 proenzyme and increased collagen degradation. In tumor spheroid outgrowth assays, cell migration of MT-MMP-1 transfectants relative to control was enhanced on collagen and decreased on vitronectin and fibronectin. These effects were reversed by TIMP-2 and were not associated with any substantial changes in cell adhesion. Binding of U251.3 cells to the C-terminal domain of MMP-2 was specifically inhibited by anti-(alpha)vss3 integrin blocking antibody indicating that MMP-2 interacts with (alpha)vss3 through the enzyme's C-terminal portion at or near the integrin's matrix adhesion sites. We propose that these mechanisms could govern directed matrix degradation in the tumor cells' microenvironment by sequestration of active MMP-2 on the cell surface. Our data suggest that activation of MMP-2 and its proteolytic activity localized to the cell surface could differentially modulate tumor cell migration in response to particular matrix proteins by altering both composition of the extracellular matrix and expression of adhesion receptors on the cell surface.

[1]  A. Strongin,et al.  Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. , 1997, Anticancer Research.

[2]  Z. Werb,et al.  Metalloproteinases regulate parietal endoderm differentiating and migrating in cultured mouse embryos , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[3]  J. Greene,et al.  Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4* , 1996, The Journal of Biological Chemistry.

[4]  E. Engvall,et al.  Human glioma U‐251 cells contain type 1 plasminogen activator inhibitor in a rapidly releasable form , 1996, FEBS letters.

[5]  A. Strongin,et al.  A Novel Monoclonal Antibody, L1A3, Is Directed to the Functional Site of the αv Integrin Subunit , 1996 .

[6]  Y. Okada,et al.  Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. , 1996, Cancer research.

[7]  Z. Gokaslan,et al.  Modulation of matrix metalloprotease-2 and invasion in human glioma cells by α3β1 integrin , 1996 .

[8]  W. Stetler-Stevenson,et al.  Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.

[9]  Jeffrey C. Allen,et al.  Migration of Brain Tumor Cells on Extracellular Matrix Proteins in Vitro Correlates with Tumor Type and Grade and Involves αv and β1 Integrins , 1996 .

[10]  S. Weiss,et al.  Transmembrane-deletion Mutants of the Membrane-type Matrix Metalloproteinase-1 Process Progelatinase A and Express Intrinsic Matrix-degrading Activity (*) , 1996, The Journal of Biological Chemistry.

[11]  E. Deryugina,et al.  Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. , 1996, Journal of cell science.

[12]  M. Ailenberg,et al.  Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP). , 1996, The Biochemical journal.

[13]  L. Liotta,et al.  Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. , 1996, Cancer research.

[14]  Hiroshi Sato,et al.  Identification of the Second Membrane-type Matrix Metalloproteinase (MT-MMP-2) Gene from a Human Placenta cDNA Library , 1995, The Journal of Biological Chemistry.

[15]  A. Nakano,et al.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. , 1995, Journal of neurosurgery.

[16]  B. Hinzmann,et al.  cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. , 1995, European journal of biochemistry.

[17]  Z. Werb,et al.  Components of the nuclear signaling cascade that regulate collagenase gene expression in response to integrin-derived signals , 1995, The Journal of cell biology.

[18]  W. Stetler-Stevenson,et al.  Tissue Inhibitor of Metalloproteinase-2 Stimulates Fibroblast Proliferation via a cAMP-dependent Mechanism (*) , 1995, The Journal of Biological Chemistry.

[19]  J. Heino,et al.  Integrin α2β1 Is a Positive Regulator of Collagenase (MMP-1) and Collagen α1(I) Gene Expression (*) , 1995, The Journal of Biological Chemistry.

[20]  Z. Werb,et al.  Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin , 1995, The Journal of cell biology.

[21]  L. Zardi,et al.  Different Susceptibility of Small and Large Human Tenascin-C Isoforms to Degradation by Matrix Metalloproteinases (*) , 1995, The Journal of Biological Chemistry.

[22]  P. Chambon,et al.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  James P. Quigley,et al.  Matrix Metalloproteinase-2 Is an Interstitial Collagenase , 1995, The Journal of Biological Chemistry.

[24]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[25]  W. Stetler-Stevenson,et al.  Gelatinase A activity directly modulates melanoma cell adhesion and spreading. , 1995, The EMBO journal.

[26]  Y. DeClerck,et al.  Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. , 1994, Cancer research.

[27]  W. Stetler-Stevenson,et al.  TIMP‐2 Expression Modulates Human Melanoma Cell Adhesion and Motility , 1994, Annals of the New York Academy of Sciences.

[28]  J. Woessner.  The Family of Matrix Metalloproteinasesa , 1994 .

[29]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[30]  W. Stetler-Stevenson,et al.  Tissue inhibitor of metalloproteinases‐2 inhibits bFGF‐induced human microvascular endothelial cell proliferation , 1993, Journal of cellular physiology.

[31]  D A Lauffenburger,et al.  Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength , 1993, The Journal of cell biology.

[32]  M. Bourdon,et al.  Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. , 1993, Journal of cell science.

[33]  A. Strongin,et al.  Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. , 1993, The Journal of biological chemistry.

[34]  L. Liotta,et al.  Molecular aspects of tumor cell invasion and metastasis , 1993, Cancer.

[35]  M. Cockett,et al.  The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.

[36]  E. Howard,et al.  Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. , 1991, The Journal of biological chemistry.

[37]  A. Eisen,et al.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  L. Coussens,et al.  Matrix metalloproteinases and the development of cancer. , 1996, Chemistry & biology.

[39]  D. Zagzag,et al.  Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. , 1996, Cancer research.

[40]  Z. Gokaslan,et al.  Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. , 1996, Cancer letters.

[41]  J. Quigley,et al.  Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. , 1995, The Journal of biological chemistry.

[42]  Z. Werb,et al.  Integrins, Signaling, and the Remodeling of the Extracellular Matrix , 1994 .

[43]  J. Woessner.  The family of matrix metalloproteinases. , 1994, Annals of the New York Academy of Sciences.

[44]  L. Liotta,et al.  Tumor cell interactions with the extracellular matrix during invasion and metastasis. , 1993, Annual review of cell biology.

[45]  H. Birkedal‐Hansen,et al.  Matrix metalloproteinases: a review. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[46]  E. Engvall,et al.  Fibronectin: purification, immunochemical properties, and biological activities. , 1982, Methods in enzymology.

[47]  M. Bourdon,et al.  Endothelial cell attachment and spreading on human tenascin is mediated by 2 1 and V 3 integrins , 2022 .